Prof. Stefan Engelter, MD
Position(s)
Head of Rehabilitation
Senior Physician Neurology
Institution
University Geriatric Medicine FELIX PLATTER
University Hospital Basel
Phone
+41 61 326 41 30
Read more
Research Group Stefan Engelter
Research Focus
Neurology
Area of Research
Clinical Stroke Research. Carotid and vertebral artery dissection. Stroke genetics. Thrombolysis and thrombectomy in acute stroke. Evidence-based therapy. Non-vitamin K antagonists and stroke, cerebral hemorrhage. Stroke in the elderly, neurorehabilitation after stroke.
Approved Research Projects
RCTs.
- TREAT-CAD (PI) “Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection“ (TREAT-CAD) (https://clinicaltrials.gov/ct2/show/NCT02046460)
- ESTREL (PI) “Enhancement of Stroke Rehabilitation With Levodopa (ESTREL)” (https://clinicaltrials.gov/ct2/show/NCT03735901)
- TWIST (national coordinator Switzerland) Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST) https://clinicaltrials.gov/ct2/show/NCT03181360
- TICH-NOAC (Co-Chair) Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist (TICH-NOAC) (https://clinicaltrials.gov/ct2/show/NCT02866838)
Investigator-initiated Research Initiatives (European Research Consortia):
- Cervical Artery Dissection in Ischemic Stroke Patients (CADISP): Founding member; Member of Scientific Committee
- Thrombolysis in Ischemic Stroke Patients (TRISP): Initiator; Lead coordinator
- Novel Oral AntiCoagulants in Stroke Patients (NOACISP): Initiator (https://clinicaltrials.gov/ct2/show/NCT03826927)
Collaborations
National Collaborations
- ESTREL
International Collaborations
- TRISP
- CADISP (Cervical artery dissection in stroke patients)
- TREAT-CAD
- ESTREL
Ongoing Research Projects
- “Enhancement of Stroke Rehabilitation With Levodopa (ESTREL)” (https://clinicaltrials.gov/ct2/show/NCT03735901)
- Databank cleaning, adjudication of outcome events “ Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection“ (TREAT-CAD) (https://clinicaltrials.gov/ct2/show/NCT02046460)
- “New Oral Anticoagulants in Stroke Patients” (NOACISP) – a registry with a focus on very aged or multimorbid patients (https://clinicaltrials.gov/ct2/show/NCT03826927)